Safety Net Providers Oppose 2-Tier Drug Pricing Policy
Safety net providers, which historically work in underserved communities, have petitioned state legislatures to take action on 340B 2-tier pricing.
Survey: Millennials Least Likely to Get Flu Shot, More Likely to Agree with Anti-Vaccination Beliefs
According to the survey, certain groups, including millennials and African Americans, are more susceptible to anti-vaccination
PTSD can have debilitating effects, including flashbacks, nightmares, and extreme anxiety.
Pfizer will become the first to launch 3 oncology monoclonal antibody biosimilar treatments to the US market.
Suzanne Soliman, PharmD, BCMAS, Founder and President of Pharmacist Moms, discusses her coalition, and their overall mission in the pharmaceutical landscape.
The study was the first to examine proton pump inhibitors use in breast cancer survivors.
Oprah Winfrey visited a pharmacy in Charlotte, North Carolina, during her 2020 Vision tour to raise awareness about mental and physical health.
Top news of the day from across the health care landscape.
Opioid agonist therapy (OAT) must be widely disseminated and increased in Ukraine in order to optimize HIV prevention and treatment goals, according to a recent study published in The Lancet.
Pharmacists should advise patients to get vaccinated at least 1 month before going abroad.
An introduction to practice pearl #1 with identifying severity of disease, and determining goals of therapy.
A proposed FDA guidance could significantly impact veterinary practices and their ability to compound medicines for animal patients, according to a national survey.1
A study published in the American Journal of Pharmaceutical Education conducted focus groups of pharmacy preceptors to discuss desired business-related skills.
Valoctocogene roxaparvovec (Valrox, BioMarin Pharmaceutical Inc) would be the first gene therapy in the United States for the most common form of hemophilia if approved by the FDA.1
The Importance of Cross-Functional Collaboration in Revenue Integrity
Girish Dighe, PharmD, MS, explains why it is important to understand more than just the revenue integrity piece of the puzzle.